GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aevi Genomic Medicine Inc (LSE:MEDU) » Definitions » Notes Receivable

Aevi Genomic Medicine (LSE:MEDU) Notes Receivable : £0.00 Mil (As of Sep. 2019)


View and export this data going back to . Start your Free Trial

What is Aevi Genomic Medicine Notes Receivable?

Aevi Genomic Medicine's Notes Receivable for the quarter that ended in Sep. 2019 was £0.00 Mil.


Aevi Genomic Medicine Notes Receivable Historical Data

The historical data trend for Aevi Genomic Medicine's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aevi Genomic Medicine Notes Receivable Chart

Aevi Genomic Medicine Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Aevi Genomic Medicine Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Aevi Genomic Medicine Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Aevi Genomic Medicine Notes Receivable Related Terms

Thank you for viewing the detailed overview of Aevi Genomic Medicine's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Aevi Genomic Medicine (LSE:MEDU) Business Description

Traded in Other Exchanges
N/A
Address
435 Devon Park Drive, Suite 715, Wayne, PA, USA, 19087
Medgenics is a clinical-stage biopharmaceutical company involved mainly in genomic medicine. Genomic medicine involves the usage of individual's genomic information to decide upon clinical care. This medical discipline is used in the fields of oncology, pharmacology, rare and undiagnosed diseases, and infectious diseases. Medgenics' partner is the Center for Applied Genomics at the Children's Hospital of Philadelphia, with which it works to develop drugs by implementing genomics medicine.

Aevi Genomic Medicine (LSE:MEDU) Headlines

No Headlines